This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Savid Therapeutics Inc.. Active years: 2017-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tokushima, JP (2017 - 2021)
- Osaka, JP (2022)
Company Filing History:
Years Active: 2017-2022
Title: Tatsuya Kawato: Innovator in Biochemical Engineering
Introduction
Tatsuya Kawato, an acclaimed inventor based in Tokushima, Japan, has made significant contributions in the field of biochemical engineering. With a total of three patents to his name, his work focuses predominantly on modified biotin and streptavidin mutants, showcasing his innovative spirit and dedication to scientific research.
Latest Patents
Kawato's latest inventions include two crucial advancements: a modified biotin and a streptavidin mutant. The objective of these inventions is to create a streptavidin mutant that has reduced affinity to naturally-occurring biotin, while simultaneously providing a modified biotin that demonstrates a high affinity to this particular streptavidin mutant. These innovations culminate in the formulation of a compound composed of a dimer of modified biotin and a streptavidin mutant, which has potential applications across various biochemical fields.
Career Highlights
Employed at Savid Therapeutics Inc., Tatsuya Kawato has positioned himself as a prominent figure within the scientific community. His work continues to pave the way for advancements in therapeutic solutions through the utilization of his patented inventions.
Collaborations
Kawato's accomplishments are further complemented by his collaboration with esteemed coworkers, such as Akira Sugiyama and Hirofumi Doi. Together, they foster a creative environment that encourages innovation and the development of cutting-edge technologies in biochemical research.
Conclusion
In summary, Tatsuya Kawato exemplifies the spirit of innovation through his groundbreaking work in the field of biochemical engineering. His patents, particularly in modified biotin and streptavidin mutants, not only highlight his expertise but also have the potential to transform current practices in therapeutics. As he continues to advance scientific knowledge alongside his colleagues, the impact of his work is expected to resonate widely across the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile